Quick Answer
ARTELO BIOSCIENCES, INC. reported Stockholders Equity of -$1.27 million for fiscal year 2025.
ARTELO BIOSCIENCES, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$1.27M | -144.5% |
| 2024 | $2.86M | -75.7% |
| 2023 | $11.75M | -39.4% |
| 2022 | $19.40M | -28.6% |
| 2021 | $27.17M | +125.6% |
| 2021 | $12.04M | +210.8% |
| 2020 | $3.88M | -29.0% |
| 2019 | $5.46M | +4145.2% |
| 2018 | -$135.0K | -124.8% |
| 2017 | $544.8K | +4048.1% |
| 2016 | -$13.8K | -186.8% |
| 2015 | $15.9K | +7.9% |
| 2014 | $14.7K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$633.0K | -110.0% | +55.0% |
| June 30, 2025 | -$1.41M | -119.3% | -315.6% |
| March 31, 2025 | $652.0K | -93.2% | -77.2% |
| December 31, 2024 | $2.86M | -75.7% | -55.1% |
| September 30, 2024 | $6.36M | -56.4% | -12.9% |
| June 30, 2024 | $7.30M | -55.1% | -23.5% |
| March 31, 2024 | $9.54M | -45.9% | -18.8% |
| December 31, 2023 | $11.75M | -39.4% | -19.4% |
- ARTELO BIOSCIENCES, INC. showed a decrease of -144.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2014–2025 period, ARTELO BIOSCIENCES, INC.’s stockholders equity has declined by 8734.9% (from $14.7 thousand to -$1.27 million).
- The most recent figure is from ARTELO BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: